Minghui Li

Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma

Q. Yin, Xudong Wei, Jian-wei Du, 2014, Leukemia & lymphoma.

Clinical and epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae infections in a tertiary hospital in China

Lirui Wang, Yuexia Li, Wei-Tein Chang, 2021, SSRN Electronic Journal.

Clinical Characteristics of Carbapenem-Resistant Klebsiella Pneumoniaee Infections In A Tertiary Hospital In China

Lirui Wang, Yuexia Li, Min Feng, 2021 .

Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales

Liang Chen, Xiudi Han, Yanli Li, 2021, Antimicrobial agents and chemotherapy.

Clinical observation on the safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantation.

F. Yuan, Yongqi Wang, Minghui Li, 2023, Biotechnology & genetic engineering reviews.

Long-Term Outcome of Centrally Located Hepatocellular Carcinomas Treated by Radical Resection Combined With Intraoperative Electron Radiotherapy (IOERT)

Q. Feng, J. Cai, Y. Zhai, 2022, Frontiers in Oncology.

Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma

Q. Yin, Xudong Wei, Jian-wei Du, 2014, Leukemia & lymphoma.